Literature DB >> 3022253

Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate-induced analgesia in mice.

M Kavaliers, K P Ossenkopp.   

Abstract

An exposure for 60 min to a 0.5 Hz rotating magnetic field (1.5-90 G) significantly attenuated the daytime analgesic effects of the mu and kappa opiate agonists, morphine and U50,488H, respectively, and significantly inhibited the analgesic actions of the delta agonist, D-Ala2-D-Leu5-enkephalin, in mice. The magnetic stimuli had no significant effects on the analgesic effects of the prototypic sigma opiate agonist (+/-) SKF-10,047. These results show that exposure to relatively weak magnetic stimuli has significant and differential inhibitory influences on various opioid systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022253     DOI: 10.1016/0196-9781(86)90013-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Stress-induced opioid analgesia and activity in mice: inhibitory influences of exposure to magnetic fields.

Authors:  M Kavaliers; K P Ossenkopp
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Calcium channel involvement in magnetic field inhibition of morphine-induced analgesia.

Authors:  M Kavaliers; K P Ossenkopp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

3.  Magnetic fields inhibit opioid-mediated 'analgesic' behaviours of the terrestrial snail, Cepaea nemoralis.

Authors:  M Kavaliers; K P Ossenkopp
Journal:  J Comp Physiol A       Date:  1988-03       Impact factor: 1.836

4.  Early exposure to intermediate-frequency magnetic fields alters brain biomarkers without histopathological changes in adult mice.

Authors:  Tin-Tin Win-Shwe; Shin Ohtani; Akira Ushiyama; Naoki Kunugita
Journal:  Int J Environ Res Public Health       Date:  2015-04-22       Impact factor: 3.390

5.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.